SOPH

SOPHiA GENETICS SA Ordinary Shares

HealthcareHealth Information ServicesSwitzerlandNASDAQ

$5.07

-4.16%today

MKT CAP

$359M

+2.0% · 1Y

Full Financials

Trailing P/E-

Forward P/E-9.6x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ+11.5%

5y Revenue CAGR+17.6%

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership8.4%

Institutional Ownership48.4%

Short % of Float0.26%

Days to Cover1.8d

1 Week+1.4%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
NRC National Research Corporation Common Stock (Delaware)	$406M	42	48.0	16.1	-	-	-	-	320.00%
EVH Evolent Health Inc Class A Common Stock	$441M	100	-	9.7	-	-	-	-	0.00%
CTEV Claritev Corporation Class A Common Stock	$455M	100	-	3.5	-	-	-	-	0.00%
CARL Carlsmed Inc. Common Stock	$270M	5	-	-	-	-	-	-	0.00%
LFMD LifeMD Inc. Common Stock	$251M	80	-	11.7	-	-	-	-	0.00%
PHR Phreesia Inc. Common Stock	$574M	58	245.8	5.7	-	-	-	-	0.00%